|
2024
|
Invention
|
Bispecific antibody that binds to cd116 and cd131.
An object of the present invention is to prov... |
|
|
Invention
|
Compound with anticancer activity.
A compound having anticancer activity, or a pharmaceutically ... |
|
|
Invention
|
Methods for treating hypertension using an anti-bmp10 monoclonal antibody or fragment thereof.
A... |
|
|
Invention
|
Prophylactic and/or therapeutic agent for kidney diseases containing tricyclic compound. Provided... |
|
|
Invention
|
Pharmaceutical composition.
The present invention relates to a therapeutic agent for an ophthalm... |
|
|
Invention
|
Bispecific antibody that binds to cd116 and cd131. An object of the present invention is to provi... |
|
2023
|
Invention
|
Synthetic adsorbent, antibody purification method, and antibody production method.
A synthetic a... |
|
|
P/S
|
Pharmaceutical preparations. Providing medical information. |
|
|
Invention
|
Anti-human ccr1 monoclonal antibody.
A monoclonal antibody is provided which binds to a human CC... |
|
|
Invention
|
Method for producing quinoxaline derivative. The present invention provides a method for producin... |
|
|
Invention
|
Bispecific antibody which binds to cd40 and epcam.
The purpose of the present invention is to pr... |
|
|
Invention
|
Anti-fgf23 antibody, and fragment of said antibody. The present invention pertains to: an antibod... |
|
|
Invention
|
Effective and efficient control of serum phosphate for optimal bone formation.
The present inven... |
|
|
Invention
|
Antibody which binds to myelin oligodendrocyte glycoprotein.
The invention relates to an antibod... |
|
|
P/S
|
Providing medical information. |
|
|
Invention
|
Method for selecting cell.
A method for selecting a cell strain in which reduction of a recombin... |
|
|
Invention
|
Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine.
... |
|
|
Invention
|
Antibody or fragment thereof that binds to fcrl1. The present invention relates to: a monoclonal ... |
|
|
Invention
|
Pharmaceutical composition for blood cell recovery after cord blood transplant. The present inven... |
|
|
Invention
|
Compound with anticancer activity. A compound having anticancer activity, or a pharmaceutically a... |
|
2022
|
P/S
|
providing medical information. |
|
|
Invention
|
Methods for treating hypertension using an anti-bmp10 monoclonal antibody or fragment thereof. An... |
|
|
Invention
|
Bispecific antibody that binds to cd116 and cd131. The purpose of the present invention is to pro... |
|
|
Invention
|
Polynucleotide and pharmaceutical composition.
The present invention relates to a polynucleotide... |
|
|
Invention
|
Polynucleotide and pharmaceutical composition. The present invention relates to a polynucleotide ... |
|
|
Invention
|
Polynucleotide and medicinal composition. The present invention relates to a polynucleotide inclu... |
|
|
Invention
|
Synthetic adsorbent, antibody purification method, and antibody production method. In this synthe... |
|
|
P/S
|
Electronic data collection of clinical data related to clinical trials of pharmaceuticals in medi... |
|
|
P/S
|
Collection and computerized management of clinical data related to clinical trials of pharmaceuti... |
|
|
P/S
|
Collection and computerized management of clinical data
related to clinical trials of pharmaceut... |
|
|
Invention
|
Method for suppressing production of degradation products.
An object of the present invention is... |
|
|
Invention
|
Method for suppressing production of degradation products. The purpose of the present invention i... |
|
|
P/S
|
Host cells for medical or clinical use; cells for medical use, namely, cells that manufacture ant... |
|
|
P/S
|
Pharmaceuticals. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer or malignant tumors, pain, hematological ... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceuticals. |
|
|
Invention
|
Composition and ameliorating agent having inflammation reducing effect.
The present invention re... |
|
|
Invention
|
Composition and ameliorating agent having inflammation reducing effect. The present invention per... |
|
|
Invention
|
Composition and improving agent having inflammation-suppressing action. The present invention rel... |
|
2021
|
Invention
|
Treatment or prevention method of radiation damage by administration of il-5 receptor alpha chain... |
|
|
Invention
|
Methods for treating tumor-induced osteomalacia. The present invention provides compositions and ... |
|
|
Invention
|
Human monoclonal antibody human cd134 (ox40) and methods of making and using same.
The invention... |
|
|
Invention
|
Therapeutic agent for a tumor comprising an ido inhibitor administered in combination with an ant... |
|
|
Invention
|
Method for treating ox40 related disease.
The present disclosure relates to an anti-OX40 antibod... |
|
|
Invention
|
Method for treating ox40 related disease. The present disclosure relates to an anti-OX40 antibody... |
|
|
P/S
|
Contract manufacturing service in the field of antibodies, fragments of antibodies, and derivativ... |
|
|
P/S
|
Vitamins for use in the manufacture of food supplements, food and beverages; Oligosaccharides bei... |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer and immune-related diseases and disorders; ph... |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer and
immune-related diseases and disorders; p... |
|
|
P/S
|
Pharmaceuticals comprising antibodies, fragments of
antibodies and derivatives of antibodies; ce... |
|
|
P/S
|
Human pharmaceutical products for the treatment of cancer; human pharmaceutical products for the ... |
|
|
P/S
|
Pharmaceuticals comprising monospecific, bispecific or multispecific antibodies, fragments of mon... |
|
|
Invention
|
Antibody composition.
An object of the present invention is to provide an antibody composition, ... |
|
|
Invention
|
Bispecific antibody binding to cd3.
An object of the present invention is to provide a bispecifi... |
|
|
P/S
|
Pharmaceuticals; pharmaceutical preparations; pharmaceutical
preparations for the treatment of s... |
|
2020
|
Invention
|
Polynucleotide and pharmaceutical composition.
An object of the present invention is to provide ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer and T-cell lymphoma. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer and T-cell lymphoma |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
Invention
|
Bet degrader.
The present invention provides a BET (protein) degrader, specifically a BET degrad... |
|
|
Invention
|
Dcr3 variant.
An object of the present invention is to provide a DcR3 variant that has binding a... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of X-linked hypophosphatemia; pharmaceutical prepar... |
|
|
P/S
|
Pharmaceuticals. Providing medical information, physical examination, dietary
and nutritional gu... |
|
|
Invention
|
Method for purifying antibody using adsorbent.
An object of the present invention is to provide,... |
|
|
P/S
|
Providing medical information; physical examination; dietary
and nutritional guidance. |
|
|
Invention
|
Bispecific antibody binding to cd40 and fap.
An object of the present invention is to provide a ... |
|
|
Invention
|
Bispecific antibody binding to cd40 and gpc3.
An object of the present invention is to provide a... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of the central nervous system disorders; pharmaceut... |
|
|
Invention
|
Therapeutic agent for parkinson's disease.
A therapeutic agent for Parkinson's disease containin... |
|
|
Invention
|
Method for treating preeclampsia.
A composition containing antithrombin and a method for treatin... |
|
2019
|
Invention
|
Fn14 antibodies and uses thereof. An antibody or antigen binding fragment thereof that binds to a... |
|
|
Invention
|
Nucleic acid conjugate.
The present invention provides a nucleic acid conjugate represented by t... |
|
|
P/S
|
Pharmaceutical preparations; Pharmaceuticals. |
|
|
P/S
|
Pharmaceutical preparations; medicines for human purposes;
medicine for veterinary purposes. |
|
|
P/S
|
Pharmaceuticals; Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparation for the treatment of congenital and acquired antithrombin deficiency; ... |
|
2017
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
P/S
|
Diagnostic preparations for medical purposes; pharmaceutical preparation for the treatment of can... |
|
|
P/S
|
Medical services, providing medical information, physical examination, dentistry, preparation and... |
|
|
P/S
|
Medical services; providing medical information; physical examination services; dentistry service... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of X-linked hypophosphatemia; Pharmaceutical prepar... |
|
|
P/S
|
Pharmaceutical preparations. Electronic publications, downloadable. Printed matter, printed publi... |
